Piperacillin/Tazobactam Fresenius i.v. 2 g/0.25 g, Pulver zur Herstellung einer Infusionslösung

7680630010018 CH-63001 Pulver
Piperacillin/Tazobactam Fresenius i.v. 2 g/0.25 g, Pulver zur Herstellung einer Infusionslösung
Piperacillin/Tazobactam Fresenius i.v. 2 g/0.25 g, Pulver zur Herstellung einer Infusionslösung
Piperacillin/Tazobactam Fresenius i.v. 2 g/0.25 g, Pulver zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
30/07/2025
Summary of Product Characteristics
Français
30/07/2025
Summary of Product Characteristics
Italien
30/07/2025

Detailed composition

Substance Quantity Type Category
PRC
2.0 G Substance Wirkstoff (Principe actif)
PRC
2.085 G Substance WIZUS
PRC
250.0 MG Substance Wirkstoff (Principe actif)
PRC
268.3 MG Substance WIZUS
PRC
112.0 MG Substance HBESI

Reimbursement information

Public price
CHF 27.00
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2014

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
63001
Drug name
Piperacillin/Tazobactam Fresenius i.v., Pulver zur Herstellung einer Infusionslösung
Galenic form
PULVI
ATC Code
J01CR05
Authorization status
Z
Dispensing category
A
First authorization
05/12/2013
Authorization expiration date
31/12/9999
IT Number
08.01.93
Domain
Human medicine
Field of application
Infektionskrankheiten

Package details

Description (FR)
PIPERACILLIN/TAZOB. Fresenius i.v. 2.25 g flac
Description (DE)
PIPERACILLIN/TAZOB. Fresenius i.v. 2.25 g Durchstf
Market launch
05/12/2013
Narcotic (BTM)
No

Other package sizes (3)

None
10 DUR
GTIN: None
Not in V1
PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g flac
1 DUR
GTIN: 7680630010032
View
PIPERACILLIN/TAZOB. Fresenius i.v. 4.5 g 10 pce
10 DUR
GTIN: 7680630010049
View